Label: VERAPAMIL HYDROCHLORIDE tablet

  • NDC Code(s): 23155-026-01, 23155-026-05, 23155-059-01, 23155-486-01, view more
  • Packager: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 12, 2022

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Verapamil hydrochloride (verapamil HCl) tablets, USP is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets ...
  • CLINICAL PHARMACOLOGY
    Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) that exerts its pharmacologic effects by modulating the influx of ionic calcium across ...
  • INDICATIONS AND USAGE
    Verapamil hydrochloride tablets, USP are indicated for the treatment of the following: Angina - 1.  Angina at rest including: -  Vasospastic (Prinzmetal's variant) angina - -  Unstable ...
  • CONTRAINDICATIONS
    Verapamil HCl tablets are contraindicated in: Severe left ventricular dysfunction (see WARNINGS ) Hypotension (systolic pressure less than 90 mm Hg) or cardiogenic shock - Sick sinus syndrome ...
  • WARNINGS
    Heart failure: Verapamil has a negative inotropic effect, which in most patients is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net ...
  • PRECAUTIONS
    General - Use in patients with impaired hepatic function: Since verapamil is highly metabolized by the liver, it should be administered cautiously to patients with impaired hepatic function ...
  • Animal pharmacology and/or animal toxicology:
    In chronic animal toxicology studies, verapamil caused lenticular and/or suture line changes at 30 mg/kg/day or greater, and frank cataracts at 62.5 mg/kg/day or greater in the beagle dog but not ...
  • ADVERSE REACTIONS
    Serious adverse reactions are uncommon when verapamil hydrochloride therapy is initiated with upward dose titration within the recommended single and total daily dose. See WARNINGS for discussion ...
  • OVERDOSAGE
    Treat all verapamil overdoses as serious and maintain observation for at least 48 hours (especially Verapamil Hydrochloride Tablets SR), preferably under continuous hospital care. Delayed ...
  • DOSAGE AND ADMINISTRATION
    The dose of verapamil must be individualized by titration. The usefulness and safety of dosages exceeding 480 mg/day have not been established; therefore, this daily dosage should not be ...
  • HOW SUPPLIED
    Verapamil Hydrochloride Tablets, USP 120 mg tablets are round, standard concave, white film-coated, scored, debossed "HP" above and "27" below on one side and plain on the reverse side, supplied ...
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
    Verapamil Hydrochloride Tablets, USP, 40 mg, 100 count
  • Verapamil Hydrochloride Tablets, USP 80 mg 100 ct
    Verapamil Hydrochloride Tablets, USP 80 mg 100 ct
  • Verapamil Hydrochloride Tablets, USP, 120 mg, 100 count
    Verapamil Hydrochloride Tablets, USP, 120 mg, 100 count
  • INGREDIENTS AND APPEARANCE
    Product Information